Unknown

Dataset Information

0

CSF GFAP levels in double seronegative neuromyelitis optica spectrum disorder: no evidence of astrocyte damage.


ABSTRACT:

Background

Despite rigorous confirmation with reliable assays, some individuals showing the neuromyelitis optica spectrum disorder (NMOSD) phenotype remain negative for both aquaporin-4 (AQP4) and myelin oligodendrocyte glycoprotein (MOG) antibodies.

Objective

We aimed to investigate whether double seronegative NMOSD (DN-NMOSD) and NMOSD with AQP4 antibody (AQP4-NMOSD) share the same pathophysiological basis, astrocytopathy, by measurement of cerebrospinal fluid (CSF) glial fibrillary acidic protein (GFAP) levels as a marker of astrocyte damage.

Methods

Seventeen participants who (1) satisfied the 2015 diagnostic criteria for NMOSD, and (2) tested negative for AQP4 and MOG antibodies confirmed with repeated cell-based assays, and (3) had available CSF samples obtained at the point of clinical attacks, were enrolled from 4 medical centers (South Korea, Germany, Thailand, and Denmark). Thirty age-matched participants with AQP4-NMOSD, 17 participants with MOG antibody associated disease (MOGAD), and 15 participants with other neurological disorders (OND) were included as controls. The concentration of CSF GFAP was measured using enzyme-linked immunosorbent assay.

Results

CSF GFAP levels in the DN-NMOSD group were significantly lower than those in the AQP4-NMOSD group (median: 0.49 versus 102.9 ng/mL; p < 0.001), but similar to those in the OND (0.25 ng/mL) and MOGAD (0.39 ng/mL) control groups. The majority (90% (27/30)) of participants in the AQP4-NMOSD group showed significantly higher CSF GFAP levels than the highest level measured in the OND group, while no participant in the DN-NMOSD and MOGAD groups did.

Conclusions

These results suggest that DN-NMOSD has a different underlying pathogenesis other than astrocytopathy, distinct from AQP4-NMOSD.

SUBMITTER: Hyun JW 

PROVIDER: S-EPMC9006458 | biostudies-literature | 2022 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

CSF GFAP levels in double seronegative neuromyelitis optica spectrum disorder: no evidence of astrocyte damage.

Hyun Jae-Won JW   Kim Yeseul Y   Kim Ki Hoon KH   Kim Su-Hyun SH   Olesen Mads Nikolaj MN   Asgari Nasrin N   Siritho Sasitorn S   Paul Friedemann F   Kim Ho Jin HJ  

Journal of neuroinflammation 20220412 1


<h4>Background</h4>Despite rigorous confirmation with reliable assays, some individuals showing the neuromyelitis optica spectrum disorder (NMOSD) phenotype remain negative for both aquaporin-4 (AQP4) and myelin oligodendrocyte glycoprotein (MOG) antibodies.<h4>Objective</h4>We aimed to investigate whether double seronegative NMOSD (DN-NMOSD) and NMOSD with AQP4 antibody (AQP4-NMOSD) share the same pathophysiological basis, astrocytopathy, by measurement of cerebrospinal fluid (CSF) glial fibril  ...[more]

Similar Datasets

| S-EPMC6065055 | biostudies-literature
| S-EPMC4405292 | biostudies-literature
| S-EPMC5765249 | biostudies-literature
2021-08-24 | GSE150598 | GEO
| S-EPMC5528902 | biostudies-literature
| S-EPMC11672031 | biostudies-literature
| S-EPMC9550749 | biostudies-literature
| S-EPMC7183484 | biostudies-literature
| S-EPMC7002275 | biostudies-literature
| S-EPMC7941255 | biostudies-literature